Pee predicts cancer treatment success?
NCT ID NCT06904677
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether proteins in urine can help doctors predict how patients with advanced colorectal cancer will respond to treatment given before surgery. Researchers will collect urine samples from 400 participants before and after therapy and use advanced technology to find protein markers linked to tumor shrinkage. The goal is to develop a non-invasive way to guide treatment decisions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER (CRC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cancer Hospital Chinese Academy of Medical Sciences
RECRUITINGBeijing, Chaoyang District, 100021, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Four-Drug combo erase Triple-Negative breast cancer before surgery?
- Why are more younger adults getting colorectal cancer? a national study digs into the data
- Can a triple threat of drug, immunotherapy, and radiation wipe out High-Risk urinary tract cancer before surgery?
- Could a Triple-Drug attack before surgery eliminate more breast cancer in older women?
- New drug combo aims to boost response in Hard-to-Treat colorectal cancer
- Modified herpes virus joins forces with immunotherapy to attack head and neck tumors